SCHEMBL9540153

SCHEMBL9540153

CCn1c(-c2ccccc2)c2cc(Cl)ccc2nc1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
MAPK1 P28482 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C19 P33261 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
DPP4 P27487 1/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 1/20 0.48
FABP3 P05413 2/20 0.46
FABP4 P15090 2/20 0.46
FABP5 Q01469 1/20 0.46
ALDH1A1 P00352 3/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MAT2A P31153 2/20 0.44
ACSS2 Q9NR19 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9539053 0.84 MAPT (0.50) KDM4EL3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL9540062 0.82 KDM4E (0.51) KDM4EL3MBTL1CYP2C9MAPK1MAPT
SCHEMBL9539742 0.81 AURKA (0.52) KDM4EL3MBTL1MAPTLMNAHTT
SCHEMBL9539113 0.78 KDM4E (0.48) KDM4EL3MBTL1CYP2C9MAPK1MAPT
SCHEMBL11157753 0.77 MAPT (0.61) KDM4EL3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL9540165 0.75 KDM4E (0.47) KDM4EL3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL11542655 0.73 DPP4 (0.48) KDM4EL3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL9541577 0.73 KDM4E (0.45) KDM4EL3MBTL1MAPK1MAPTLMNA
SCHEMBL8347845 0.71 SMN1; SMN2 (0.60) KDM4EL3MBTL1CYP1A2CYP3A4CYP2C9
SCHEMBL9539747 0.70 KDM4E (0.47) KDM4EL3MBTL1CYP1A2CYP2C9MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed